Metraipolis › archive › dc_33d9b406eebe

Predictors of response and survival in cemiplimab-treated cutaneous squamous cell carcinoma: multicenter real-world evidence from Germany — Europe PMC PMID:41739240

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41739240
DOI
10.1007/s00432-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-05T07:52:53.152Z
SHA-256 of the archived text
f4e27fb84c39d37d8e21efca1ce3ed2fa9c20ec6488200e11da79be135c02087
Stable URL of this page
https://metraipolis.com/documento/dc_33d9b406eebe

How to cite

Predictors of response and survival in cemiplimab-treated cutaneous squamous cell carcinoma: multicenter real-world evidence from Germany — Europe PMC PMID:41739240 — Europe PMC (en), https://europepmc.org/article/MED/41739240 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_33d9b406eebe (Metraipolis archive dc_33d9b406eebe, sha256 f4e27fb84c39d37d8e21efca1ce3ed2fa9c20ec6488200e11da79be135c02087)
BibTeX
@misc{dc33d9b406eebe,
  title = {Predictors of response and survival in cemiplimab-treated cutaneous squamous cell carcinoma: multicenter real-world evidence from Germany — Europe PMC PMID:41739240},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41739240},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_33d9b406eebe; sha256 f4e27fb84c39d37d8e21efca1ce3ed2fa9c20ec6488200e11da79be135c02087},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41739240. Agents can read the archived copy with the MCP tool read_document.